Verona wins COPD nod, FDA rejects Merck-Daiichi ADC, Glenmark recalls potassium chloride capsules [The good, the bad, the ugly]

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:  

The good — Verona wins FDA nod for COPD 
The bad — FDA issues CRL to Merck-Daiichi lung cancer ADC 
The ugly — Glenmark recalls 114 batches of potassium chloride capsules